Description

DuPont Is Not Just A Chemicals Giant Anymore — Healthcare, Water & Semiconductors Reshape Growth!

DuPont’s second quarter 2026 results reflected continued execution of its strategic priorities, with solid organic sales growth, margin expansion, and strong cash flow generation. The company reported net sales of $1.8 billion, up 4% organically year-over-year, driven by broad-based strength across healthcare, aerospace, industrial water, semiconductor, building technologies, and diversified industrial end markets. Operating EBITDA grew 8% to $448 million, with margins expanding by 80 basis points to 24.6%, despite a 30 basis point headwind from oil and gas-related price and cost dynamics. Adjusted EPS increased 21% year-over-year to $1.88, supported by operational improvements and below-the-line benefits. Segment-wise, the Healthcare & Water Technologies unit posted 5% net sales growth driven by double-digit gains in personal protection and biopharma markets and industrial water and semiconductor growth, although Middle East market challenges weighed on water sales. Margins for this segment declined 30 basis points amid growth investments and less favorable product mix.